|
WO2020118054A1
|
|
Compositions for stabilizing bacteria and uses thereof
|
|
EP3801065A1
|
|
Designed bacterial compositions and uses thereof
|
|
CN112118852A
|
|
Compositions and methods for treating inflammatory bowel disease
|
|
CA3095356A1
|
|
Microbiome compositions for treatment of cancer
|
|
EP3703720A1
|
|
Compositions and methods for treating antibiotic resistance
|
|
AU2018346255A1
|
|
Manipulation of tryptamine metabolism
|
|
CN111212655A
|
|
Compositions and methods for treating cholestatic diseases
|
|
EP3380108A2
|
|
Designed bacterial compositions
|
|
AU2016290956A1
|
|
Methods of treating colitis
|
|
WO2015095241A2
|
|
Bacterial compositions and methods of use thereof for treatment of immune system disorders
|
|
CN105979952A
|
|
Synergistic bacterial compositions and methods of production and use thereof
|
|
US2016030494A1
|
|
Network-based microbial compositions and methods
|
|
EP2971148A2
|
|
Methods for pathogen detection and enrichment from materials and compositions
|
|
EP2951283A1
|
|
Compositions and methods
|
